Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2021-02-16 3:24 pm Sale | 13G | DAVE & BUSTERS ENTERTAINMENT I PLAY | Point72 Asset Management L.P. | 826,620 1.7% | -2,631,094 (-76.09%) | View |
2021-02-16 3:23 pm Sale | 13G | FINTECH ACQUISITION CORP III C FTAC | Point72 Asset Management L.P. | 0 0% | -2,480,013 (Position Closed) | View |
2021-02-16 3:22 pm Sale | 13G | FULCRUM THERAPEUTICS INC FULC | Point72 Asset Management L.P. | 1,338,668 4.9% | -43,340 (-3.14%) | View |
2021-02-16 3:21 pm Sale | 13G | MACROGENICS INC MGNX | Point72 Asset Management L.P. | 1,475,558 2.6% | -1,235,305 (-45.57%) | View |
2021-02-16 3:20 pm Sale | 13G | NETFIN ACQUISITION CORP SHS CL NFIN | Point72 Asset Management L.P. | 0 0% | -1,675,000 (Position Closed) | View |
2021-02-16 3:20 pm Purchase | 13G | PORCH GROUP INC PRCH | Point72 Asset Management L.P. | 1,572,175 2% | 1,572,175 (New Position) | View |
2021-02-16 3:19 pm Purchase | 13G | REVOLVE GROUP INC RVLV | Point72 Asset Management L.P. | 1,724,536 6.7% | 585,407 (+51.39%) | View |
2021-02-16 3:18 pm Sale | 13G | CHILDRENS PL INC PLCE | Point72 Asset Management L.P. | 295,236 2% | -460,143 (-60.92%) | View |
2021-02-16 3:16 pm Sale | 13G | CYTOKINETICS INC CYTK | Point72 Asset Management L.P. | 1,176,653 1.7% | -1,855,196 (-61.19%) | View |
2021-02-16 3:16 pm Sale | 13G | BIOCRYST PHARMACEUTICALS INC BCRX | Point72 Asset Management L.P. | 3,691,632 2.1% | -4,696,422 (-55.99%) | View |
2021-02-16 3:15 pm Purchase | 13G | BELLUS HEALTH INC BLU | Point72 Asset Management L.P. | 6,240,116 8% | 20,058 (+0.32%) | View |
2021-02-16 3:14 pm Purchase | 13G | AEGLEA BIOTHERAPEUTICS, INC. C AGLE | Point72 Asset Management L.P. | 2,929,787 6.1% | 41,811 (+1.45%) | View |
2021-02-16 3:13 pm Sale | 13G | APTEVO THERAPEUTICS INC APVO | Point72 Asset Management L.P. | 0 0% | -4,050,100 (Position Closed) | View |
2021-02-16 3:13 pm Sale | 13G | BREAD FINANCIAL HOLDINGS INC. BFH | Point72 Asset Management L.P. | 898,522 1.8% | -1,519,206 (-62.84%) | View |
2021-02-16 3:12 pm Sale | 13G | SYROS PHARMACEUTICALS INC SYRS | Point72 Asset Management L.P. | 39,691 0.1% | -2,275,475 (-98.29%) | View |
2021-02-16 3:11 pm Sale | 13G | SUNOPTA INC STKL | Point72 Asset Management L.P. | 62,298 0.1% | -5,461,179 (-98.87%) | View |
2021-02-16 3:10 pm Sale | 13G | ACORDA THERAPEUTICS INC ACOR | Point72 Asset Management L.P. | 903,364 1.9% | -3,798,564 (-80.79%) | View |
2021-02-16 3:09 pm Purchase | 13G | OAKTREE ACQUISITION CORP OAC | Point72 Asset Management L.P. | 1,300,100 6.5% | 185,000 (+16.59%) | View |
2021-02-16 3:09 pm Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Point72 Asset Management L.P. | 426,162 10.9% | 426,162 (New Position) | View |
2021-02-08 5:21 pm Purchase | 13G | AFFIMED N V AFMD | Point72 Asset Management L.P. | 5,814,606 5% | 5,814,606 (New Position) | View |